Heat shock protein-90 dampens and directs signaling stimulated by insulin-like growth factor-1 and insulin

被引:30
|
作者
Meares, GP [1 ]
Zmijewska, AA [1 ]
Jope, RS [1 ]
机构
[1] Univ Alabama, Dept Psychiat & Behav Neurobiol, Sparks Ctr 1057, Birmingham, AL 35294 USA
来源
FEBS LETTERS | 2004年 / 574卷 / 1-3期
关键词
heat shock protein-90; Akt; protein kinase B; insulin; insulin-like growth factor-1;
D O I
10.1016/j.febslet.2004.08.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heat shock protein-90 (Hsp90) buffers cells from genetic mutations and environmental stresses. To test if this capability reflects a normal physiological function of Hsp90 to buffer cellular signals, the effects of Hsp90 inhibition were measured on activation of Akt. Inhibition of Hsp90 with geldanamycin amplified Akt phosphorylation induced by insulin-like growth factor-1 (IGF-1) or insulin, indicating that Hsp90 normally buffers these signals. Furthermore, with IGF-1 stimulation Hsp90 inhibition increased p38 activation, produced additive activation of p90RSK, and slightly increased the duration of ERK1/2 activation. Hsp90 dampened Akt signaling by facilitating phosphatase-mediated dephosphorylation of Akt. Thus, Hsp90 not only buffers the cellular effects of mutations and stresses, but also buffers the magnitude and duration of activation of proliferative and survival-promoting signaling responses. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 50 条
  • [11] Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction
    Jiang, Jue
    Chen, Zhifeng
    Liang, Bing
    Yan, Jia
    Zhang, Ying
    Jiang, Hong
    SPRINGERPLUS, 2015, 4 : 1 - 7
  • [12] Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
    Fabbi, Patrizia
    Spallarossa, Paolo
    Garibaldi, Silvano
    Barisione, Chiara
    Mura, Marzia
    Altieri, Paola
    Rebesco, Barbara
    Monti, Maria Gaia
    Canepa, Marco
    Ghigliotti, Giorgio
    Brunelli, Claudio
    Ameri, Pietro
    PLOS ONE, 2015, 10 (05):
  • [13] Growth Hormone and Insulin-Like Growth Factor-1
    Nicholls, Adam R.
    Holt, Richard I. G.
    SPORTS ENDOCRINOLOGY, 2016, 47 : 101 - 114
  • [15] Central Insulin and Insulin-Like Growth Factor-1 Signaling - Implications for Diabetes Associated Dementia
    Zemva, Johanna
    Schubert, Markus
    CURRENT DIABETES REVIEWS, 2011, 7 (05) : 356 - 366
  • [16] Does hypoxia only influence insulin-like growth factor-1 through insulin-like growth factor binding protein-1?
    Sun, Miao
    Li, Qian
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (06) : 1831 - 1831
  • [17] The effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in cavernous nerve cryoablation
    Bochinski, DJ
    Hsieh, PS
    Chen, KC
    Yeh, CH
    Nunes, L
    Lin, GT
    Lin, CS
    Spencer, M
    Deng, D
    Lue, T
    JOURNAL OF UROLOGY, 2003, 169 (04): : 313 - 313
  • [18] Insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in women with premenstrual syndrome
    Rapkin, AJ
    Cedars, M
    Morgan, M
    Goldman, L
    FERTILITY AND STERILITY, 1998, 70 (06) : 1077 - 1080
  • [19] Elevated insulin-like growth factor-1 and insulin-like growth factor binding protein-2 in malignant pleural effusion
    Olchovsky, D
    Shimon, I
    Goldberg, I
    Shulimzon, T
    Lubetsky, A
    Yellin, A
    Pariente, C
    Karasik, A
    Kanety, H
    ACTA ONCOLOGICA, 2002, 41 (02) : 182 - 187
  • [20] Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical prostatectomy
    Bubley, GJ
    Balk, SP
    Regan, MM
    Duggan, S
    Morrissey, ME
    Dewolf, WC
    Salgami, E
    Mantzoros, C
    JOURNAL OF UROLOGY, 2002, 168 (05): : 2249 - 2252